Robust feedback design for combined therapy of cancer
From MaRDI portal
Publication:5408038
DOI10.1002/oca.2057zbMath1284.93075MaRDI QIDQ5408038
Publication date: 8 April 2014
Published in: Optimal Control Applications and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/oca.2057
parameter uncertainty; nonlinear robust control; combined therapy of cancer; guaranteed tumor contraction; Hamilton-Jacobi-Isaacs PDE's
93B35: Sensitivity (robustness)
93C20: Control/observation systems governed by partial differential equations
93B52: Feedback control
92C50: Medical applications (general)
Related Items
Probabilistically certified region of attraction of a tumor growth model with combined chemo‐ and immunotherapy, Learning-based sensitivity analysis and feedback design for drug delivery of mixed therapy of cancer in the presence of high model uncertainties, On probabilistic certification of combined cancer therapies using strongly uncertain models, Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control, Iterative method for estimating the robust domains of attraction of non-linear systems: application to cancer chemotherapy model with parametric uncertainties
Cites Work
- Unnamed Item
- Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes
- A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
- Robust constrained control algorithm for general batch processes
- Solutions of nonlinear optimal and robust control problems via a mixed collocation/DAE's based algorithm